{"parse":{"title":"CimaVax-EGF","pageid":34024745,"revid":844899975,"text":{"*":"<div class=\"mw-parser-output\"><p><b>CimaVax-EGF</b> is a <a href=\"/wiki/Cancer_vaccine\" title=\"Cancer vaccine\">vaccine used to treat cancer</a>, specifically <a href=\"/wiki/Non-small-cell_lung_carcinoma\" title=\"Non-small-cell lung carcinoma\">non-small-cell lung carcinoma</a> (NSCLC).  CIMAvax-EGF is composed of <a href=\"/wiki/Recombinant_protein\" class=\"mw-redirect\" title=\"Recombinant protein\">recombinant</a> human <a href=\"/wiki/Epidermal_growth_factor\" title=\"Epidermal growth factor\">epidermal growth factor (EGF)</a> conjugated to a protein carrier.<sup id=\"cite_ref-Cro2015_1-0\" class=\"reference\"><a href=\"#cite_note-Cro2015-1\">&#91;1&#93;</a></sup>\n</p><p>The vaccine was developed by the <a href=\"/wiki/Center_of_Molecular_Immunology\" title=\"Center of Molecular Immunology\">Center of Molecular Immunology</a>, <a href=\"/wiki/Havana,_Cuba\" class=\"mw-redirect\" title=\"Havana, Cuba\">Havana, Cuba</a><sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> There are agreements in place to test it in the United States, Japan, and some European countries.<sup id=\"cite_ref-Patel2013_4-0\" class=\"reference\"><a href=\"#cite_note-Patel2013-4\">&#91;4&#93;</a></sup> It is currently available in Cuba, Colombia, Bosnia and Herzegovina, Peru and Paraguay.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> In October 2015 <a href=\"/wiki/Serbia\" title=\"Serbia\">Serbia</a>'s Institute of Virology, Vaccines and Sera (AKA Torlak Institute) signed a memorandum for use in 30 patients as part of a study.<sup id=\"cite_ref-TorlakInstitute_6-0\" class=\"reference\"><a href=\"#cite_note-TorlakInstitute-6\">&#91;6&#93;</a></sup> CimaVax is relatively cheap to produce and store, and has low toxicity.<sup id=\"cite_ref-Patel2013_4-1\" class=\"reference\"><a href=\"#cite_note-Patel2013-4\">&#91;4&#93;</a></sup> Side effects of the vaccine appear to be mild, and include chills, fever, and feeling sick.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-Rodriguez2012_8-0\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Mechanism\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Mechanism</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Research\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Research</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Cuba\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Cuba</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#International\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">International</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Mechanism\">Mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CimaVax-EGF&amp;action=edit&amp;section=1\" title=\"Edit section: Mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>CimaVax is an active <a href=\"/wiki/Vaccine\" title=\"Vaccine\">vaccine</a> with which patients are immunized with <a href=\"/wiki/Epidermal_growth_factor\" title=\"Epidermal growth factor\">epidermal growth factor</a> (EGF), thus raising <a href=\"/wiki/Antibodies\" class=\"mw-redirect\" title=\"Antibodies\">antibodies</a> targeting EGF itself. The product is also formulated with the <i><a href=\"/wiki/Neisseria_meningitidis\" title=\"Neisseria meningitidis\">Neisseria meningitidis</a></i> outer protein <a href=\"/w/index.php?title=P64k&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"P64k (page does not exist)\">P64k</a> and <a href=\"/w/index.php?title=Montanide_ISA_51&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Montanide ISA 51 (page does not exist)\">Montanide ISA 51</a> as <a href=\"/wiki/Adjuvant\" title=\"Adjuvant\">adjuvants</a> to potentiate the immune response.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup><sup id=\"cite_ref-Rodriguez2012_8-1\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> The <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">epidermal growth factor receptor</a> (EGFR) is hijacked by many types of cancer, including cancers of the lung, colon, kidney, and head and neck. By raising antibodies against EGF, which is EGFR's major <a href=\"/wiki/Ligand\" title=\"Ligand\">ligand</a>, the concentrations of EGF in the blood are reduced. Thus CimaVax does not target the cancer cells directly, but is expected to work against these cancers by denying the cancers the growth stimulus they require.<sup id=\"cite_ref-Rodriguez2012_8-2\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-NeningerVinageras2008_10-0\" class=\"reference\"><a href=\"#cite_note-NeningerVinageras2008-10\">&#91;10&#93;</a></sup> For this reason, the Roswell Park group thinks that it may prove most useful as a <i>preventive</i> vaccine rather than as a cancer therapy <i>per se</i>.<sup id=\"cite_ref-Patel2013_4-2\" class=\"reference\"><a href=\"#cite_note-Patel2013-4\">&#91;4&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CimaVax-EGF&amp;action=edit&amp;section=2\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Cuba\">Cuba</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CimaVax-EGF&amp;action=edit&amp;section=3\" title=\"Edit section: Cuba\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Early trials showed a trend towards improved survival among vaccinated test subjects.<sup id=\"cite_ref-Rodriguez2012_8-3\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> A direct correlation between the level of antibodies that a vaccinated patient raises against EGF and survival has been observed in several trials,<sup id=\"cite_ref-Rodriguez2012_8-4\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> and in one of the largest trials<sup id=\"cite_ref-NeningerVinageras2008_10-1\" class=\"reference\"><a href=\"#cite_note-NeningerVinageras2008-10\">&#91;10&#93;</a></sup> there was also an age-dependence, with only subjects under the age of 60 benefiting in terms of survival.<sup id=\"cite_ref-Rodriguez2012_8-5\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> More antibodies are raised when the vaccine is formulated with Montanide ISA 51 rather than <a href=\"/wiki/Aluminum_hydroxide\" class=\"mw-redirect\" title=\"Aluminum hydroxide\">aluminum hydroxide</a>  as an adjuvant, and when patients receive a low dose of <a href=\"/wiki/Cyclophosphamide\" title=\"Cyclophosphamide\">cyclophosphamide</a> three days before vaccine administration.<sup id=\"cite_ref-Rodriguez2012_8-6\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> Cyclophosphamide is thought to temporarily block the body's natural <a href=\"/wiki/Immune_tolerance\" title=\"Immune tolerance\">immune tolerance</a> to EGF, thereby increasing antibody titers.<sup id=\"cite_ref-Rodriguez2012_8-7\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup>\n</p><p>Researchers caution that the early results to date have been in relatively small, early-stage trials with patients that were carefully selected based on predefined inclusion and exclusion criteria, and given specialized oncology care; they may therefore not be representative of most patients who might benefit from the vaccine.<sup id=\"cite_ref-Rodriguez2012_8-8\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> It has been urged that CimaVax be tested in patients with earlier-stage NSCLC cancer and in patients who are not candidates for <a href=\"/wiki/Chemotherapy\" title=\"Chemotherapy\">chemotherapy</a>, and that research be conducted to determine which subgroups of NSCLC patients do and don't respond to the vaccine.<sup id=\"cite_ref-Rodriguez2012_8-9\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup> It has been suggested that CimaVax may also be effective in other types of cancer that are dependent on EGF/EGFR, including many cases of <a href=\"/wiki/Prostate_cancer\" title=\"Prostate cancer\">prostate cancer</a>.<sup id=\"cite_ref-Rodriguez2012_8-10\" class=\"reference\"><a href=\"#cite_note-Rodriguez2012-8\">&#91;8&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"International\">International</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CimaVax-EGF&amp;action=edit&amp;section=4\" title=\"Edit section: International\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Trials are being organized in the United States, the European Union, Japan,<sup id=\"cite_ref-Patel2013_4-3\" class=\"reference\"><a href=\"#cite_note-Patel2013-4\">&#91;4&#93;</a></sup> and Serbia.<sup id=\"cite_ref-TorlakInstitute_6-1\" class=\"reference\"><a href=\"#cite_note-TorlakInstitute-6\">&#91;6&#93;</a></sup> In late October 2016, the <a href=\"/wiki/United_States_Food_and_Drug_Administration\" class=\"mw-redirect\" title=\"United States Food and Drug Administration\">United States Food and Drug Administration</a> authorized<sup id=\"cite_ref-Davis2016_12-0\" class=\"reference\"><a href=\"#cite_note-Davis2016-12\">&#91;12&#93;</a></sup> the Roswell Park Cancer Institute to conduct a PhaseI/II clinical trial of CimaVAX in patients with non-small cell lung cancer.<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> By the middle of the following month, nearly 200 people had volunteered to be subjects in the trial.<sup id=\"cite_ref-Hoshaw2016_14-0\" class=\"reference\"><a href=\"#cite_note-Hoshaw2016-14\">&#91;14&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=CimaVax-EGF&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Cro2015-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Cro2015_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Crombet Ramos, T; Rodr\u00edguez, PC; Neninger Vinageras, E; Garcia Verdecia, B; Lage Davila, A (2015). \"CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer\". <i>Expert review of vaccines</i>. <b>14</b> (10): 1303\u201311. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1586/14760584.2015.1079488\">10.1586/14760584.2015.1079488</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26295963\">26295963</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+review+of+vaccines&amp;rft.atitle=CIMAvax+EGF+%28EGF-P64K%29+vaccine+for+the+treatment+of+non-small-cell+lung+cancer.&amp;rft.volume=14&amp;rft.issue=10&amp;rft.pages=1303-11&amp;rft.date=2015&amp;rft_id=info%3Adoi%2F10.1586%2F14760584.2015.1079488&amp;rft_id=info%3Apmid%2F26295963&amp;rft.aulast=Crombet+Ramos&amp;rft.aufirst=T&amp;rft.au=Rodr%C3%ADguez%2C+PC&amp;rft.au=Neninger+Vinageras%2C+E&amp;rft.au=Garcia+Verdecia%2C+B&amp;rft.au=Lage+Davila%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Dillow, C. (8 September 2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.popsci.com/science/article/2011-09/cuba-releases-worlds-first-lung-cancer-vaccine\">\"Cuba Announces Release of the World's First Lung Cancer Vaccine\"</a>. <i><a href=\"/wiki/Popular_Science\" title=\"Popular Science\">Popular Science</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2011-12-11</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Popular+Science&amp;rft.atitle=Cuba+Announces+Release+of+the+World%27s+First+Lung+Cancer+Vaccine&amp;rft.date=2011-09-08&amp;rft.aulast=Dillow&amp;rft.aufirst=C.&amp;rft_id=http%3A%2F%2Fwww.popsci.com%2Fscience%2Farticle%2F2011-09%2Fcuba-releases-worlds-first-lung-cancer-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Grillo, I. (23 April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.globalpost.com/article/6526566/2015/04/23/cuba-lung-cancer-vaccine-new-york\">\"Cuba has had a lung cancer vaccine for years\"</a>. <i><a href=\"/wiki/GlobalPost\" title=\"GlobalPost\">GlobalPost</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2014-05-24</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GlobalPost&amp;rft.atitle=Cuba+has+had+a+lung+cancer+vaccine+for+years&amp;rft.date=2015-04-23&amp;rft.aulast=Grillo&amp;rft.aufirst=I.&amp;rft_id=http%3A%2F%2Fwww.globalpost.com%2Farticle%2F6526566%2F2015%2F04%2F23%2Fcuba-lung-cancer-vaccine-new-york&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Patel2013-4\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Patel2013_4-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Patel2013_4-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Patel2013_4-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Patel2013_4-3\"><sup><i><b>d</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation news\">Patel, N. (11 May 2015). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.wired.com/2015/05/cimavax-roswell-park-cancer-institute/\">\"Cuba Has a Lung Cancer Vaccine\u2014And America Wants It\"</a>. <i><a href=\"/wiki/Wired_(website)\" class=\"mw-redirect\" title=\"Wired (website)\">Wired</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-05-13</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Wired&amp;rft.atitle=Cuba+Has+a+Lung+Cancer+Vaccine%E2%80%94And+America+Wants+It&amp;rft.date=2015-05-11&amp;rft.aulast=Patel&amp;rft.aufirst=N.&amp;rft_id=https%3A%2F%2Fwww.wired.com%2F2015%2F05%2Fcimavax-roswell-park-cancer-institute%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Tamayo, H. (8 September 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.eltiempo.com/colombia/medellin/vacuna-contra-cancer-de-pulmon-en-colombia/16696285\">\"Vacuna contra c\u00e1ncer de pulm\u00f3n llega al pa\u00eds\"</a>. <i><a href=\"/wiki/El_Tiempo_(Colombia)\" title=\"El Tiempo (Colombia)\">El Tiempo (Colombia)</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-09-09</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=El+Tiempo+%28Colombia%29&amp;rft.atitle=Vacuna+contra+c%C3%A1ncer+de+pulm%C3%B3n+llega+al+pa%C3%ADs&amp;rft.date=2016-09-08&amp;rft.aulast=Tamayo&amp;rft.aufirst=H.&amp;rft_id=http%3A%2F%2Fwww.eltiempo.com%2Fcolombia%2Fmedellin%2Fvacuna-contra-cancer-de-pulmon-en-colombia%2F16696285&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-TorlakInstitute-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-TorlakInstitute_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-TorlakInstitute_6-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.b92.net/eng/news/society.php?yyyy=2015&amp;mm=10&amp;dd=21&amp;nav_id=95795\">\"<span style=\"padding-left:0.2em;\">'</span>Cuban anti-cancer vaccines soon to be available in Serbia<span style=\"padding-right:0.2em;\">'</span>\"</a>. October 21, 2015.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=%27Cuban+anti-cancer+vaccines+soon+to+be+available+in+Serbia%27&amp;rft.date=2015-10-21&amp;rft_id=http%3A%2F%2Fwww.b92.net%2Feng%2Fnews%2Fsociety.php%3Fyyyy%3D2015%26mm%3D10%26dd%3D21%26nav_id%3D95795&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancerresearchuk.org/about-cancer/cancers-in-general/cancer-questions/can-you-tell-me-about-the-cimavax-lung-cancer-vaccine\">\"Can you tell me about the CimaVax lung cancer vaccine?\"</a>. <a href=\"/wiki/Cancer_Research_UK\" title=\"Cancer Research UK\">Cancer Research UK</a>. 12 May 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-07-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Can+you+tell+me+about+the+CimaVax+lung+cancer+vaccine%3F&amp;rft.pub=Cancer+Research+UK&amp;rft.date=2015-05-12&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fabout-cancer%2Fcancers-in-general%2Fcancer-questions%2Fcan-you-tell-me-about-the-cimavax-lung-cancer-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Rodriguez2012-8\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Rodriguez2012_8-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-Rodriguez2012_8-10\"><sup><i><b>k</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rodr\u00edguez, P. C.; Rodr\u00edguez, G.; Gonz\u00e1lez, G.; Lage, A. (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicc.org/mediccreview/index.php?issue=11&amp;id=128&amp;a=vahtml\">\"Clinical development and perspectives of CIMAvax EGF, Cuban vaccine for non-small-cell lung cancer therapy\"</a>. <i><a href=\"/w/index.php?title=MEDICC_Review&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"MEDICC Review (page does not exist)\">MEDICC Review</a></i>. <b>12</b> (1): 17\u201323. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20387330\">20387330</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=MEDICC+Review&amp;rft.atitle=Clinical+development+and+perspectives+of+CIMAvax+EGF%2C+Cuban+vaccine+for+non-small-cell+lung+cancer+therapy&amp;rft.volume=12&amp;rft.issue=1&amp;rft.pages=17-23&amp;rft.date=2010&amp;rft_id=info%3Apmid%2F20387330&amp;rft.aulast=Rodr%C3%ADguez&amp;rft.aufirst=P.+C.&amp;rft.au=Rodr%C3%ADguez%2C+G.&amp;rft.au=Gonz%C3%A1lez%2C+G.&amp;rft.au=Lage%2C+A.&amp;rft_id=http%3A%2F%2Fwww.medicc.org%2Fmediccreview%2Findex.php%3Fissue%3D11%26id%3D128%26a%3Dvahtml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\">P\u00e9rez A, et al. <a rel=\"nofollow\" class=\"external text\" href=\"http://onlinelibrary.wiley.com/doi/10.1042/BA20010029/abstract\">Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers</a>. Biotechnol Appl Biochem. 2001 Oct;34(Pt 2):121-5. PubMed <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11592918\">11592918</a>.</span>\n</li>\n<li id=\"cite_note-NeningerVinageras2008-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-NeningerVinageras2008_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-NeningerVinageras2008_10-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Neninger Vinageras, E.; de la Torre, A.; Osorio Rodr\u00edguez, M.; Catal\u00e1 Ferrer, M.; Bravo, I.; Mendoza del Pino, M.; Abreu Abreu, D.; Acosta Brooks, S.; Rives, R.; del Castillo Carrillo, C.; Gonz\u00e1lez Due\u00f1as, M.; Viada, C.; Garc\u00eda Verdecia, B.; Crombet Ramos, T.; Gonz\u00e1lez Marinello, G.; Lage D\u00e1vila, A. (2008). <a rel=\"nofollow\" class=\"external text\" href=\"http://jco.ascopubs.org/content/26/9/1452.long\">\"Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer\"</a>. <i><a href=\"/wiki/Journal_of_Clinical_Oncology\" title=\"Journal of Clinical Oncology\">Journal of Clinical Oncology</a></i>. <b>26</b> (9): 1452\u20131458. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1200/JCO.2007.11.5980\">10.1200/JCO.2007.11.5980</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18349395\">18349395</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.atitle=Phase+II+randomized+controlled+trial+of+an+epidermal+growth+factor+vaccine+in+advanced+non-small-cell+lung+cancer&amp;rft.volume=26&amp;rft.issue=9&amp;rft.pages=1452-1458&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2007.11.5980&amp;rft_id=info%3Apmid%2F18349395&amp;rft.aulast=Neninger+Vinageras&amp;rft.aufirst=E.&amp;rft.au=de+la+Torre%2C+A.&amp;rft.au=Osorio+Rodr%C3%ADguez%2C+M.&amp;rft.au=Catal%C3%A1+Ferrer%2C+M.&amp;rft.au=Bravo%2C+I.&amp;rft.au=Mendoza+del+Pino%2C+M.&amp;rft.au=Abreu+Abreu%2C+D.&amp;rft.au=Acosta+Brooks%2C+S.&amp;rft.au=Rives%2C+R.&amp;rft.au=del+Castillo+Carrillo%2C+C.&amp;rft.au=Gonz%C3%A1lez+Due%C3%B1as%2C+M.&amp;rft.au=Viada%2C+C.&amp;rft.au=Garc%C3%ADa+Verdecia%2C+B.&amp;rft.au=Crombet+Ramos%2C+T.&amp;rft.au=Gonz%C3%A1lez+Marinello%2C+G.&amp;rft.au=Lage+D%C3%A1vila%2C+A.&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcontent%2F26%2F9%2F1452.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Rodriguez, P. C.; Neninger, E.; Garc\u00eda, B.; Popa, X.; Viada, C.; Luaces, P.; Gonz\u00e1lez, G.; Lage, A.; Montero, E.; Crombet, T. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jibtherapies.com/content/9/1/7\">\"Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients\"</a>. <i><a href=\"/w/index.php?title=Journal_of_Immune_Based_Therapies_and_Vaccines&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Journal of Immune Based Therapies and Vaccines (page does not exist)\">Journal of Immune Based Therapies and Vaccines</a></i>. <b>9</b> (7): 7. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1476-8518-9-7\">10.1186/1476-8518-9-7</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Immune+Based+Therapies+and+Vaccines&amp;rft.atitle=Safety%2C+immunogenicity+and+preliminary+efficacy+of+multiple-site+vaccination+with+an+Epidermal+Growth+Factor+%28EGF%29+based+cancer+vaccine+in+advanced+non+small+cell+lung+cancer+%28NSCLC%29+patients&amp;rft.volume=9&amp;rft.issue=7&amp;rft.pages=7&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.1186%2F1476-8518-9-7&amp;rft.aulast=Rodriguez&amp;rft.aufirst=P.+C.&amp;rft.au=Neninger%2C+E.&amp;rft.au=Garc%C3%ADa%2C+B.&amp;rft.au=Popa%2C+X.&amp;rft.au=Viada%2C+C.&amp;rft.au=Luaces%2C+P.&amp;rft.au=Gonz%C3%A1lez%2C+G.&amp;rft.au=Lage%2C+A.&amp;rft.au=Montero%2C+E.&amp;rft.au=Crombet%2C+T.&amp;rft_id=http%3A%2F%2Fwww.jibtherapies.com%2Fcontent%2F9%2F1%2F7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Davis2016-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Davis2016_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Davis, Henry (26 October 2016). <a rel=\"nofollow\" class=\"external text\" href=\"http://buffalonews.com/2016/10/26/roswell-park-gets-go-ahead-test-cuban-lung-cancer-vaccine/\">\"Roswell Park gets go-ahead to test Cuban lung cancer vaccine\"</a>. <i>The Buffalo News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 December</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Buffalo+News&amp;rft.atitle=Roswell+Park+gets+go-ahead+to+test+Cuban+lung+cancer+vaccine&amp;rft.date=2016-10-26&amp;rft.aulast=Davis&amp;rft.aufirst=Henry&amp;rft_id=http%3A%2F%2Fbuffalonews.com%2F2016%2F10%2F26%2Froswell-park-gets-go-ahead-test-cuban-lung-cancer-vaccine%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://clinicaltrials.gov/ct2/show/NCT02955290\">\"CIMAvax Vaccine and Nivolumab in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Full Text View - ClinicalTrials.gov\"</a>. <i>clinicaltrials.gov</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-04-02</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=clinicaltrials.gov&amp;rft.atitle=CIMAvax+Vaccine+and+Nivolumab+in+Treating+Patients+With+Stage+IIIB-IV+Non-small+Cell+Lung+Cancer+-+Full+Text+View+-+ClinicalTrials.gov&amp;rft_id=https%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT02955290&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hoshaw2016-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Hoshaw2016_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\">Hoshaw, Lindsey (2 December 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://ww2.kqed.org/futureofyou/2016/11/16/cuba-has-a-lung-cancer-vaccine-now-u-s-patients-will-test-it/\">\"Cuba Has a Lung Cancer Vaccine; Now U.S. Patients Will Test It\"</a>. <i>KQED News</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">3 December</span> 2016</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=KQED+News&amp;rft.atitle=Cuba+Has+a+Lung+Cancer+Vaccine%3B+Now+U.S.+Patients+Will+Test+It&amp;rft.date=2016-12-02&amp;rft.aulast=Hoshaw&amp;rft.aufirst=Lindsey&amp;rft_id=https%3A%2F%2Fww2.kqed.org%2Ffutureofyou%2F2016%2F11%2F16%2Fcuba-has-a-lung-cancer-vaccine-now-u-s-patients-will-test-it%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ACimaVax-EGF\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1320\nCached time: 20180909185946\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.196 seconds\nReal time usage: 0.223 seconds\nPreprocessor visited node count: 917/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 26149/2097152 bytes\nTemplate argument size: 245/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 20926/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.090/10.000 seconds\nLua memory usage: 3.18 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  168.234      1 Template:Reflist\n100.00%  168.234      1 -total\n 44.15%   74.276      4 Template:Cite_journal\n 15.54%   26.145      5 Template:Cite_web\n 12.30%   20.696      4 Template:Cite_news\n 10.18%   17.131      1 Template:PMID\n  9.00%   15.142      1 Template:Catalog_lookup_link\n  4.15%    6.987      2 Template:Yesno-no\n  2.29%    3.850      2 Template:Yesno\n  1.39%    2.336      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:34024745-0!canonical and timestamp 20180909185946 and revision id 844899975\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/CimaVax-EGF","langname":"Spanish","autonym":"espa\u00f1ol","*":"CimaVax-EGF"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/CimaVax-EGF","langname":"Portuguese","autonym":"portugu\u00eas","*":"CimaVax-EGF"}],"categories":[{"sortkey":"","*":"Cancer_vaccines"},{"sortkey":"","*":"Health_in_Cuba"},{"sortkey":"","*":"Cuban_inventions"}],"links":[{"ns":0,"exists":"","*":"Adjuvant"},{"ns":0,"exists":"","*":"Aluminum hydroxide"},{"ns":0,"exists":"","*":"Antibodies"},{"ns":0,"exists":"","*":"Cancer Research UK"},{"ns":0,"exists":"","*":"Cancer vaccine"},{"ns":0,"exists":"","*":"Center of Molecular Immunology"},{"ns":0,"exists":"","*":"Chemotherapy"},{"ns":0,"exists":"","*":"Cyclophosphamide"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"El Tiempo (Colombia)"},{"ns":0,"exists":"","*":"Epidermal growth factor"},{"ns":0,"exists":"","*":"Epidermal growth factor receptor"},{"ns":0,"exists":"","*":"GlobalPost"},{"ns":0,"exists":"","*":"Havana, Cuba"},{"ns":0,"exists":"","*":"Immune tolerance"},{"ns":0,"exists":"","*":"Journal of Clinical Oncology"},{"ns":0,"exists":"","*":"Ligand"},{"ns":0,"exists":"","*":"Neisseria meningitidis"},{"ns":0,"exists":"","*":"Non-small-cell lung carcinoma"},{"ns":0,"exists":"","*":"Popular Science"},{"ns":0,"exists":"","*":"Prostate cancer"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Recombinant protein"},{"ns":0,"exists":"","*":"Serbia"},{"ns":0,"exists":"","*":"United States Food and Drug Administration"},{"ns":0,"exists":"","*":"Vaccine"},{"ns":0,"exists":"","*":"Wired (website)"},{"ns":0,"*":"MEDICC Review"},{"ns":0,"*":"Journal of Immune Based Therapies and Vaccines"},{"ns":0,"*":"P64k"},{"ns":0,"*":"Montanide ISA 51"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:PMID"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["//doi.org/10.1586/14760584.2015.1079488","//www.ncbi.nlm.nih.gov/pubmed/26295963","http://www.popsci.com/science/article/2011-09/cuba-releases-worlds-first-lung-cancer-vaccine","http://www.globalpost.com/article/6526566/2015/04/23/cuba-lung-cancer-vaccine-new-york","https://www.wired.com/2015/05/cimavax-roswell-park-cancer-institute/","http://www.eltiempo.com/colombia/medellin/vacuna-contra-cancer-de-pulmon-en-colombia/16696285","http://www.b92.net/eng/news/society.php?yyyy=2015&mm=10&dd=21&nav_id=95795","http://www.cancerresearchuk.org/about-cancer/cancers-in-general/cancer-questions/can-you-tell-me-about-the-cimavax-lung-cancer-vaccine","http://www.medicc.org/mediccreview/index.php?issue=11&id=128&a=vahtml","//www.ncbi.nlm.nih.gov/pubmed/20387330","http://onlinelibrary.wiley.com/doi/10.1042/BA20010029/abstract","//www.ncbi.nlm.nih.gov/pubmed/11592918","http://jco.ascopubs.org/content/26/9/1452.long","//doi.org/10.1200/JCO.2007.11.5980","//www.ncbi.nlm.nih.gov/pubmed/18349395","http://www.jibtherapies.com/content/9/1/7","//doi.org/10.1186/1476-8518-9-7","http://buffalonews.com/2016/10/26/roswell-park-gets-go-ahead-test-cuban-lung-cancer-vaccine/","https://clinicaltrials.gov/ct2/show/NCT02955290","https://ww2.kqed.org/futureofyou/2016/11/16/cuba-has-a-lung-cancer-vaccine-now-u-s-patients-will-test-it/"],"sections":[{"toclevel":1,"level":"2","line":"Mechanism","number":"1","index":"1","fromtitle":"CimaVax-EGF","byteoffset":2936,"anchor":"Mechanism"},{"toclevel":1,"level":"2","line":"Research","number":"2","index":"2","fromtitle":"CimaVax-EGF","byteoffset":5529,"anchor":"Research"},{"toclevel":2,"level":"3","line":"Cuba","number":"2.1","index":"3","fromtitle":"CimaVax-EGF","byteoffset":5542,"anchor":"Cuba"},{"toclevel":2,"level":"3","line":"International","number":"2.2","index":"4","fromtitle":"CimaVax-EGF","byteoffset":7946,"anchor":"International"},{"toclevel":1,"level":"2","line":"References","number":"3","index":"5","fromtitle":"CimaVax-EGF","byteoffset":9309,"anchor":"References"}],"parsewarnings":[],"displaytitle":"CimaVax-EGF","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q5120048"}]}}